Kee Song Bio-Technology Holdings Limited announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced sales was TWD 698.923 million compared to TWD 731.939 million a year ago. Operating loss was TWD 76.952 million compared to operating Income of TWD 6.558 million a year ago. Net loss was TWD 43.434 million compared to net income of TWD 1.829 million a year ago. Basic loss per share was TWD 1.18 compared to basic earnings per share of TWD 0.05 a year ago. For the half year, sales was TWD 1,481.514 million compared to TWD 1,409.658 million a year ago. Operating loss was TWD 80.059 million compared to operating Income of TWD 24.844 million a year ago. Net loss was TWD 58.071 million compared to net income of TWD 8.267 million a year ago. Basic loss per share was TWD 1.58 compared to basic earnings per share of TWD 0.22 a year ago.